Listen on the go
CORRECT!
Next question
touchNEUROLOGY touchNEUROLOGY

Start Learning

Touch Loading image
JOURNALS
Start Learning
Shaping the future of MS care with Dr Bardia Nourbakhsh: touchNEUROLOGY Future Leader 2025
JOURNALS
Start Learning
Tenecteplase receives FDA approval for acute ischemic stroke
JOURNALS
Start Learning
Perioperative Approaches to Decrease the Incidence of Postoperative Cognitive Decline and Postoperative Delirium in Older Patients
JOURNALS
Start Learning
Empowering Young People with Multiple Sclerosis
JOURNALS
Start Learning
Challenges and motivations in neurocritical care: Insights from Dr Eric Lawson
touchPANEL DISCUSSION
Start Learning
Reducing burden of disease in gMG: Exploring the role of FcRn inhibitors
CE/CME ACCREDITED
JOURNALS
Start Learning
American Academy of Sleep Medicine releases new clinical practice guidelines for treating restless legs syndrome
JOURNALS
Start Learning
New book brings Parkinson’s to life through art and empathy
JOURNALS
Start Learning
The National Multiple Sclerosis Society embarks on New Rural Health Initiative
touchIN CONVERSATION
Start Learning
Let’s talk about agitation in Alzheimer’s dementia: Prevalence, behavioural symptoms and reaching a diagnosis
CE/CME ACCREDITED

to view Favourites, Keep Notes and Track CME Credits

Favourites
New McDonald criteria elevate role of biomarkers in MS diagnosis
View
Expanding horizons for patients with Pompe disease: Using data to guide clinical practice
View
Celebrating unsung heroes: Dravet Syndrome UK launch Little Moments Matter Awards
View
Future directions in psychiatry with Dr Alexander Lisinski: touchNEUROLOGY Future Leader 2025
View
New guidelines for epilepsy and pregnancy: AAN, AES and SMFM collaboration
View
Perioperative Approaches to Decrease the Incidence of Postoperative Cognitive Decline and Postoperative Delirium in Older Patients
View
The Future of Multiple Sclerosis: A New Era
View
Shaping the future of Alzheimer’s research and career path: A Q&A with Prof. Bengt Winblad
View
Motor gains achieved by 83% of paediatric SMA patients treated with onasemnogene abeparvovec
View
Biomarkers of Smoldering Neuroinflammation in the Central Nervous System
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup